Cinven PE takes lead in life insurer International Financial as Vitruvian bids farewell
Private equity group Cinven will buy into life insurer International Financial Group (IFGL), succeeding Vitruvian Partners as majority investor for an undisclosed sum, sides said in parallel statements Tuesday (February 1).
Cinven likes the asset for "high quality" cash and capital generation, a track record of profitable growth based on a geographically diversified profile with strong market position, an M&A track record and further potential and strong management, Cinven said.
IFGL has £19 billion of assets under administration and operates through three principal brands: RL360, Ardan International and Friends Provident International. IFGL claims a global footprint and a headcount in excess of 550 people.
Luigi Sbrozzi (pictured), partner at Cinven, commented: “ Cinven is delighted to be investing in IFGL. IFGL is an established insurer with a strong market position. It has a large back book, which sits alongside an established new business franchise that is well diversified geographically. The Cinven team knows the market well through its previous life insurance investments, including Guardian in the UK and Viridium in Germany, and has a strong track record of working with companies in the sector to achieve strong growth, in particular, through buy-and-build as well as further product development and internationalisation.”
IFGL’s group chief executive David Kneeshaw said: “This is a very significant day for IFGL and will accelerate the Group’s ambitious plans for growth. Cinven share our vision for the future and their financial backing means we will be ideally-placed to expand significantly through both organic and new market growth and through further mergers and acquisition activity.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze